MB07133

DB17139InvestigationalSmall molecule

MB07133: Overview.

Formula / weight: C₁₇H₂₁N₄O₈P · 440.349 g/mol (avg)
Also known as: (2R,4S)-4-amino-1-(5-O-(2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl)-beta-d-arabinofuranosyl)-2(1H)-pyrimidinone · 2(1h)-pyrimidinone, 4-amino-1-(5-o-((2r,4s)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl)-.beta.-d-arabinofuranosyl)- · 4-amino-1-(5-o-((2r, 4s)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl)-.beta.-d-arabinofuranosyl)-2(1h)-pyrimidinone · 4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-arabinofuranosyl]-2(1H)-pyrimidinone
Code names: MB-07133 · MB-7133

Resolves to

Compound

Structure

InChIKeyHOAHIHGOMCBTFW-XCJSNOFESA-NSMILESNC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO[P@]2(=O)OCC[C@H](O2)C2=CC=NC=C2)[C@@H](O)[C@@H]1O

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of MB07133, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.